. . . . . . . "[This work suggests that PGD2 and its metabolite 15d-PGJ2 attenuate SCC proliferation in a PPAR?-dependent manner, therefore activation of PPAR? by agonists such as pioglitazone may benefit those at high risk of SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:34+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .